JAZZ: Jazz Pharmaceuticals plc Stock

by  •  • Comments Off on JAZZ: Jazz Pharmaceuticals plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6,677.18
Enterprise Value ($M) 10,883.81
Book Value ($M) 3,737.00
Book Value / Share 59.94
Price / Book 1.79
NCAV ($M) -4,220.93
NCAV / Share -67.70
Price / NCAV -1.58

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.12

Liquidity (mrq)
Quick Ratio 1.85
Current Ratio 2.24

Balance Sheet (mrq) ($M)
Current Assets 3,435.43
Assets 11,393.36
Liabilities 7,656.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,834.20
Operating Income 834.24
Net Income 414.83
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 1,092.01
Cash from Investing -163.06
Cash from Financing -305.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 10.11 -1.79
01-24 13G/A BlackRock Inc. 11.20 6.06

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ T

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 123,091 454,360 27.09
2024-04-17 136,061 499,524 27.24
2024-04-16 148,085 545,622 27.14
2024-04-15 136,528 232,566 58.71

(click for more detail)

Similar Companies
IPSC – Century Therapeutics, Inc. IRWD – Ironwood Pharmaceuticals, Inc.
ITCI – Intra-Cellular Therapies, Inc. KMDA – Kamada Ltd.
KNSA – Kiniksa Pharmaceuticals, Ltd.


Financial data and stock pages provided by
Fintel.io